Although it has not yet been established whether VEGF-induced leakage in diabetic retinopathy is directly mediated by VEGF or by secondary mediators, the fact that patients benefit from anti-VEGF therapy underlines its principal role in blood-retinal barrier (BRB) breakdown [32]. Here, VEGFA is linked to diabetic retinopathy.